Press-release for stocks related to colorectal cancer for BNTX

Prices are updated after-hours

| -5.6% | O: -0.37% H: 0.0% C: 0.0%
BNTX | $86.17 -0.27% -0.24% 2.2K

| -68.43% | O: -8.06% H: 3.28% C: 1.51%
phase 2 immunotherapy therapy cancer colorectal cancer trial

69%

31%

AGBA | News | $1.4 250.0% 35M

ZCMD | $2.18 50.35% 24M

RWOD | $12.0 50.06% 3.9M

AULT | $0.3174 31.1% 28M

WISA 4 | $7.11 20.71% 4.7M

INDO | $4.9 20.1% 2.2M

LIFW | News | $0.99 19.26% 800K

PRTG | $0.285 18.75% 140K

NURO | $4.32 18.36% 66K

HUBC | $1.52 17.83% 4.7M

Save your searches and get alerts when important news are released.